Report Cover

Global and United States Antihormonal Cancer Therapies Market Size, Status and Forecast 2021-2027


Global Antihormonal Cancer Therapies Scope and Market Size
Antihormonal Cancer Therapies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antihormonal Cancer Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
    Radiations
    Drugs
    Surgeries
    Others

Segment by Application
    Breast Cancer
    Prostate Cancer
    Other

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

By Company
    AstraZeneca
    Novartis
    Pfizer
    Sanofi
    Takeda
    Roche
    Amgen
    Samyang Biopharmaceuticals
    Tolmar
    Bluebird Bio
    Bristol-Myers Squibb
    Exelixis
    Guardant Health
    Illumina
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Antihormonal Cancer Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Radiations
        1.2.3 Drugs
        1.2.4 Surgeries
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Antihormonal Cancer Therapies Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Breast Cancer
        1.3.3 Prostate Cancer
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Antihormonal Cancer Therapies Market Perspective (2016-2027)
    2.2 Antihormonal Cancer Therapies Growth Trends by Regions
        2.2.1 Antihormonal Cancer Therapies Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Antihormonal Cancer Therapies Historic Market Share by Regions (2016-2021)
        2.2.3 Antihormonal Cancer Therapies Forecasted Market Size by Regions (2022-2027)
    2.3 Antihormonal Cancer Therapies Industry Dynamic
        2.3.1 Antihormonal Cancer Therapies Market Trends
        2.3.2 Antihormonal Cancer Therapies Market Drivers
        2.3.3 Antihormonal Cancer Therapies Market Challenges
        2.3.4 Antihormonal Cancer Therapies Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Antihormonal Cancer Therapies Players by Revenue
        3.1.1 Global Top Antihormonal Cancer Therapies Players by Revenue (2016-2021)
        3.1.2 Global Antihormonal Cancer Therapies Revenue Market Share by Players (2016-2021)
    3.2 Global Antihormonal Cancer Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Antihormonal Cancer Therapies Revenue
    3.4 Global Antihormonal Cancer Therapies Market Concentration Ratio
        3.4.1 Global Antihormonal Cancer Therapies Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Antihormonal Cancer Therapies Revenue in 2020
    3.5 Antihormonal Cancer Therapies Key Players Head office and Area Served
    3.6 Key Players Antihormonal Cancer Therapies Product Solution and Service
    3.7 Date of Enter into Antihormonal Cancer Therapies Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Antihormonal Cancer Therapies Breakdown Data by Type
    4.1 Global Antihormonal Cancer Therapies Historic Market Size by Type (2016-2021)
    4.2 Global Antihormonal Cancer Therapies Forecasted Market Size by Type (2022-2027)

5 Antihormonal Cancer Therapies Breakdown Data by Application
    5.1 Global Antihormonal Cancer Therapies Historic Market Size by Application (2016-2021)
    5.2 Global Antihormonal Cancer Therapies Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Antihormonal Cancer Therapies Market Size (2016-2027)
    6.2 North America Antihormonal Cancer Therapies Market Size by Type
        6.2.1 North America Antihormonal Cancer Therapies Market Size by Type (2016-2021)
        6.2.2 North America Antihormonal Cancer Therapies Market Size by Type (2022-2027)
        6.2.3 North America Antihormonal Cancer Therapies Market Size by Type (2016-2027)
    6.3 North America Antihormonal Cancer Therapies Market Size by Application
        6.3.1 North America Antihormonal Cancer Therapies Market Size by Application (2016-2021)
        6.3.2 North America Antihormonal Cancer Therapies Market Size by Application (2022-2027)
        6.3.3 North America Antihormonal Cancer Therapies Market Size by Application (2016-2027)
    6.4 North America Antihormonal Cancer Therapies Market Size by Country
        6.4.1 North America Antihormonal Cancer Therapies Market Size by Country (2016-2021)
        6.4.2 North America Antihormonal Cancer Therapies Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Antihormonal Cancer Therapies Market Size (2016-2027)
    7.2 Europe Antihormonal Cancer Therapies Market Size by Type
        7.2.1 Europe Antihormonal Cancer Therapies Market Size by Type (2016-2021)
        7.2.2 Europe Antihormonal Cancer Therapies Market Size by Type (2022-2027)
        7.2.3 Europe Antihormonal Cancer Therapies Market Size by Type (2016-2027)
    7.3 Europe Antihormonal Cancer Therapies Market Size by Application
        7.3.1 Europe Antihormonal Cancer Therapies Market Size by Application (2016-2021)
        7.3.2 Europe Antihormonal Cancer Therapies Market Size by Application (2022-2027)
        7.3.3 Europe Antihormonal Cancer Therapies Market Size by Application (2016-2027)
    7.4 Europe Antihormonal Cancer Therapies Market Size by Country
        7.4.1 Europe Antihormonal Cancer Therapies Market Size by Country (2016-2021)
        7.4.2 Europe Antihormonal Cancer Therapies Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Antihormonal Cancer Therapies Market Size (2016-2027)
    8.2 Asia-Pacific Antihormonal Cancer Therapies Market Size by Type
        8.2.1 Asia-Pacific Antihormonal Cancer Therapies Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Antihormonal Cancer Therapies Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Antihormonal Cancer Therapies Market Size by Type (2016-2027)
    8.3 Asia-Pacific Antihormonal Cancer Therapies Market Size by Application
        8.3.1 Asia-Pacific Antihormonal Cancer Therapies Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Antihormonal Cancer Therapies Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Antihormonal Cancer Therapies Market Size by Application (2016-2027)
    8.4 Asia-Pacific Antihormonal Cancer Therapies Market Size by Region
        8.4.1 Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Antihormonal Cancer Therapies Market Size (2016-2027)
    9.2 Latin America Antihormonal Cancer Therapies Market Size by Type
        9.2.1 Latin America Antihormonal Cancer Therapies Market Size by Type (2016-2021)
        9.2.2 Latin America Antihormonal Cancer Therapies Market Size by Type (2022-2027)
        9.2.3 Latin America Antihormonal Cancer Therapies Market Size by Type (2016-2027)
    9.3 Latin America Antihormonal Cancer Therapies Market Size by Application
        9.3.1 Latin America Antihormonal Cancer Therapies Market Size by Application (2016-2021)
        9.3.2 Latin America Antihormonal Cancer Therapies Market Size by Application (2022-2027)
        9.3.3 Latin America Antihormonal Cancer Therapies Market Size by Application (2016-2027)
    9.4 Latin America Antihormonal Cancer Therapies Market Size by Country
        9.4.1 Latin America Antihormonal Cancer Therapies Market Size by Country (2016-2021)
        9.4.2 Latin America Antihormonal Cancer Therapies Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Antihormonal Cancer Therapies Market Size (2016-2027)
    10.2 Middle East & Africa Antihormonal Cancer Therapies Market Size by Type
        10.2.1 Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2016-2027)
    10.3 Middle East & Africa Antihormonal Cancer Therapies Market Size by Application
        10.3.1 Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2016-2027)
    10.4 Middle East & Africa Antihormonal Cancer Therapies Market Size by Country
        10.4.1 Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Details
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Antihormonal Cancer Therapies Introduction
        11.1.4 AstraZeneca Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.1.5 AstraZeneca Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Antihormonal Cancer Therapies Introduction
        11.2.4 Novartis Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.2.5 Novartis Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Details
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Antihormonal Cancer Therapies Introduction
        11.3.4 Pfizer Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.3.5 Pfizer Recent Development
    11.4 Sanofi
        11.4.1 Sanofi Company Details
        11.4.2 Sanofi Business Overview
        11.4.3 Sanofi Antihormonal Cancer Therapies Introduction
        11.4.4 Sanofi Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.4.5 Sanofi Recent Development
    11.5 Takeda
        11.5.1 Takeda Company Details
        11.5.2 Takeda Business Overview
        11.5.3 Takeda Antihormonal Cancer Therapies Introduction
        11.5.4 Takeda Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.5.5 Takeda Recent Development
    11.6 Roche
        11.6.1 Roche Company Details
        11.6.2 Roche Business Overview
        11.6.3 Roche Antihormonal Cancer Therapies Introduction
        11.6.4 Roche Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.6.5 Roche Recent Development
    11.7 Amgen
        11.7.1 Amgen Company Details
        11.7.2 Amgen Business Overview
        11.7.3 Amgen Antihormonal Cancer Therapies Introduction
        11.7.4 Amgen Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.7.5 Amgen Recent Development
    11.8 Samyang Biopharmaceuticals
        11.8.1 Samyang Biopharmaceuticals Company Details
        11.8.2 Samyang Biopharmaceuticals Business Overview
        11.8.3 Samyang Biopharmaceuticals Antihormonal Cancer Therapies Introduction
        11.8.4 Samyang Biopharmaceuticals Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.8.5 Samyang Biopharmaceuticals Recent Development
    11.9 Tolmar
        11.9.1 Tolmar Company Details
        11.9.2 Tolmar Business Overview
        11.9.3 Tolmar Antihormonal Cancer Therapies Introduction
        11.9.4 Tolmar Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.9.5 Tolmar Recent Development
    11.10 Bluebird Bio
        11.10.1 Bluebird Bio Company Details
        11.10.2 Bluebird Bio Business Overview
        11.10.3 Bluebird Bio Antihormonal Cancer Therapies Introduction
        11.10.4 Bluebird Bio Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.10.5 Bluebird Bio Recent Development
    11.11 Bristol-Myers Squibb
        11.11.1 Bristol-Myers Squibb Company Details
        11.11.2 Bristol-Myers Squibb Business Overview
        11.11.3 Bristol-Myers Squibb Antihormonal Cancer Therapies Introduction
        11.11.4 Bristol-Myers Squibb Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.11.5 Bristol-Myers Squibb Recent Development
    11.12 Exelixis
        11.12.1 Exelixis Company Details
        11.12.2 Exelixis Business Overview
        11.12.3 Exelixis Antihormonal Cancer Therapies Introduction
        11.12.4 Exelixis Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.12.5 Exelixis Recent Development
    11.13 Guardant Health
        11.13.1 Guardant Health Company Details
        11.13.2 Guardant Health Business Overview
        11.13.3 Guardant Health Antihormonal Cancer Therapies Introduction
        11.13.4 Guardant Health Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.13.5 Guardant Health Recent Development
    11.14 Illumina
        11.14.1 Illumina Company Details
        11.14.2 Illumina Business Overview
        11.14.3 Illumina Antihormonal Cancer Therapies Introduction
        11.14.4 Illumina Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.14.5 Illumina Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Antihormonal Cancer Therapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Radiations Table 3. Key Players of Drugs Table 4. Key Players of Surgeries Table 5. Key Players of Others Table 6. Global Antihormonal Cancer Therapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Antihormonal Cancer Therapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Antihormonal Cancer Therapies Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Antihormonal Cancer Therapies Market Share by Regions (2016-2021) Table 10. Global Antihormonal Cancer Therapies Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Antihormonal Cancer Therapies Market Share by Regions (2022-2027) Table 12. Antihormonal Cancer Therapies Market Trends Table 13. Antihormonal Cancer Therapies Market Drivers Table 14. Antihormonal Cancer Therapies Market Challenges Table 15. Antihormonal Cancer Therapies Market Restraints Table 16. Global Antihormonal Cancer Therapies Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Antihormonal Cancer Therapies Market Share by Players (2016-2021) Table 18. Global Top Antihormonal Cancer Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antihormonal Cancer Therapies as of 2020) Table 19. Ranking of Global Top Antihormonal Cancer Therapies Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Antihormonal Cancer Therapies Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Antihormonal Cancer Therapies Product Solution and Service Table 23. Date of Enter into Antihormonal Cancer Therapies Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million) Table 26. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2016-2021) Table 27. Global Antihormonal Cancer Therapies Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Antihormonal Cancer Therapies Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Antihormonal Cancer Therapies Revenue Market Share by Application (2016-2021) Table 31. Global Antihormonal Cancer Therapies Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Antihormonal Cancer Therapies Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million) Table 34. North America Antihormonal Cancer Therapies Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Antihormonal Cancer Therapies Market Size by Application (2016-2021) (US$ Million) Table 36. North America Antihormonal Cancer Therapies Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Antihormonal Cancer Therapies Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Antihormonal Cancer Therapies Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Antihormonal Cancer Therapies Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Antihormonal Cancer Therapies Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Antihormonal Cancer Therapies Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Antihormonal Cancer Therapies Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Antihormonal Cancer Therapies Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Antihormonal Cancer Therapies Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Antihormonal Cancer Therapies Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Antihormonal Cancer Therapies Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Antihormonal Cancer Therapies Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Antihormonal Cancer Therapies Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Antihormonal Cancer Therapies Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Antihormonal Cancer Therapies Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Antihormonal Cancer Therapies Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2022-2027) & (US$ Million) Table 63. AstraZeneca Company Details Table 64. AstraZeneca Business Overview Table 65. AstraZeneca Antihormonal Cancer Therapies Product Table 66. AstraZeneca Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million) Table 67. AstraZeneca Recent Development Table 68. Novartis Company Details Table 69. Novartis Business Overview Table 70. Novartis Antihormonal Cancer Therapies Product Table 71. Novartis Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million) Table 72. Novartis Recent Development Table 73. Pfizer Company Details Table 74. Pfizer Business Overview Table 75. Pfizer Antihormonal Cancer Therapies Product Table 76. Pfizer Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million) Table 77. Pfizer Recent Development Table 78. Sanofi Company Details Table 79. Sanofi Business Overview Table 80. Sanofi Antihormonal Cancer Therapies Product Table 81. Sanofi Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million) Table 82. Sanofi Recent Development Table 83. Takeda Company Details Table 84. Takeda Business Overview Table 85. Takeda Antihormonal Cancer Therapies Product Table 86. Takeda Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million) Table 87. Takeda Recent Development Table 88. Roche Company Details Table 89. Roche Business Overview Table 90. Roche Antihormonal Cancer Therapies Product Table 91. Roche Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million) Table 92. Roche Recent Development Table 93. Amgen Company Details Table 94. Amgen Business Overview Table 95. Amgen Antihormonal Cancer Therapies Product Table 96. Amgen Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million) Table 97. Amgen Recent Development Table 98. Samyang Biopharmaceuticals Company Details Table 99. Samyang Biopharmaceuticals Business Overview Table 100. Samyang Biopharmaceuticals Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million) Table 101. Samyang Biopharmaceuticals Recent Development Table 102. Tolmar Company Details Table 103. Tolmar Business Overview Table 104. Tolmar Antihormonal Cancer Therapies Product Table 105. Tolmar Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million) Table 106. Tolmar Recent Development Table 107. Bluebird Bio Company Details Table 108. Bluebird Bio Business Overview Table 109. Bluebird Bio Antihormonal Cancer Therapies Product Table 110. Bluebird Bio Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million) Table 111. Bluebird Bio Recent Development Table 112. Bristol-Myers Squibb Company Details Table 113. Bristol-Myers Squibb Business Overview Table 114. Bristol-Myers Squibb Antihormonal Cancer Therapies Product Table 115. Bristol-Myers Squibb Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million) Table 116. Bristol-Myers Squibb Recent Development Table 117. Exelixis Company Details Table 118. Exelixis Business Overview Table 119. Exelixis Antihormonal Cancer Therapies Product Table 120. Exelixis Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million) Table 121. Exelixis Recent Development Table 122. Guardant Health Company Details Table 123. Guardant Health Business Overview Table 124. Guardant Health Antihormonal Cancer Therapies Product Table 125. Guardant Health Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million) Table 126. Guardant Health Recent Development Table 127. Illumina Company Details Table 128. Illumina Business Overview Table 129. Illumina Antihormonal Cancer Therapies Product Table 130. Illumina Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million) Table 131. Illumina Recent Development Table 132. Research Programs/Design for This Report Table 133. Key Data Information from Secondary Sources Table 134. Key Data Information from Primary Sources List of Figures Figure 1. Global Antihormonal Cancer Therapies Market Share by Type: 2020 VS 2027 Figure 2. Radiations Features Figure 3. Drugs Features Figure 4. Surgeries Features Figure 5. Others Features Figure 6. Global Antihormonal Cancer Therapies Market Share by Application: 2020 VS 2027 Figure 7. Breast Cancer Case Studies Figure 8. Prostate Cancer Case Studies Figure 9. Other Case Studies Figure 10. Antihormonal Cancer Therapies Report Years Considered Figure 11. Global Antihormonal Cancer Therapies Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Antihormonal Cancer Therapies Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Antihormonal Cancer Therapies Market Share by Regions: 2020 VS 2027 Figure 14. Global Antihormonal Cancer Therapies Market Share by Regions (2022-2027) Figure 15. Global Antihormonal Cancer Therapies Market Share by Players in 2020 Figure 16. Global Top Antihormonal Cancer Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antihormonal Cancer Therapies as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Antihormonal Cancer Therapies Revenue in 2020 Figure 18. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2016-2021) Figure 19. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2022-2027) Figure 20. North America Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Antihormonal Cancer Therapies Market Share by Type (2016-2027) Figure 22. North America Antihormonal Cancer Therapies Market Share by Application (2016-2027) Figure 23. North America Antihormonal Cancer Therapies Market Share by Country (2016-2027) Figure 24. United States Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Antihormonal Cancer Therapies Market Share by Type (2016-2027) Figure 28. Europe Antihormonal Cancer Therapies Market Share by Application (2016-2027) Figure 29. Europe Antihormonal Cancer Therapies Market Share by Country (2016-2027) Figure 30. Germany Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Antihormonal Cancer Therapies Market Share by Type (2016-2027) Figure 38. Asia-Pacific Antihormonal Cancer Therapies Market Share by Application (2016-2027) Figure 39. Asia-Pacific Antihormonal Cancer Therapies Market Share by Region (2016-2027) Figure 40. China Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Antihormonal Cancer Therapies Market Share by Type (2016-2027) Figure 48. Latin America Antihormonal Cancer Therapies Market Share by Application (2016-2027) Figure 49. Latin America Antihormonal Cancer Therapies Market Share by Country (2016-2027) Figure 50. Mexico Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Antihormonal Cancer Therapies Market Share by Type (2016-2027) Figure 54. Middle East & Africa Antihormonal Cancer Therapies Market Share by Application (2016-2027) Figure 55. Middle East & Africa Antihormonal Cancer Therapies Market Share by Country (2016-2027) Figure 56. Turkey Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. AstraZeneca Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021) Figure 60. Novartis Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021) Figure 61. Pfizer Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021) Figure 62. Sanofi Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021) Figure 63. Takeda Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021) Figure 64. Roche Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021) Figure 65. Amgen Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021) Figure 66. Samyang Biopharmaceuticals Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021) Figure 67. Tolmar Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021) Figure 68. Bluebird Bio Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021) Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021) Figure 70. Exelixis Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021) Figure 71. Guardant Health Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021) Figure 72. Illumina Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us